Диссертация (1174185), страница 40
Текст из файла (страница 40)
// Arterioscler. Thromb. Vasc. Biol. – 2012.– V.32. Issue 6. P.1505-1512.279.Goodarzi M.O., Taylor K.D., Jones M.R., Fang B., Guo X., Xiang A.H.,Buchanan T.A., Hodis H.N., Raffel L.J., Rotter J.I. Replication of calpain-10genetic association with carotid intima-media thickness. // Atherosclerosis. –2009. V.205. Issue 2.
P.503-505.280. Gorący J., Gorący I., Kaczmarczyk M., Parczewski M., Brykczyński M., ClarkJ., Safranow K., Ciechanowicz A. Low frequency haplotypes of E-selectinpolymorphisms G2692A and C1901T give increased protection from coronaryartery disease. // Med. Sci. Monit. 2011. V.17. Issue 6. P.334-340.281.Gorący J., Gorący I., Safranow K., Taryma O., Adler G., Ciechanowicz A.Lack of association of interleukin-1 gene cluster polymorphisms withangiographically documented coronary artery disease: demonstration ofassociation with hypertension in the Polish population. // Arch.
Med. Res. – 2011.V.42. Issue 5. P.426-432.282. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity.// Nat. Rev.Immunol. – 2005. V.5. – P.953-964.283. Gordon S. Macrophage heterogeneity and tissue lipids. // J. Clin. Invest. –2007. V.117. – P.89-93.284. GownA.M.,TsukadaImmunocytochemicalanalysisT.,ofRosstheR.Humancellularatherosclerosis.compositionofII.humanatherosclerotic lesions. // Am. J. Pathol.
– 1986. V.125. – P.191-207.285. Graham I., Atar D., Borch-Johnsen K. European guidelines on cardiovasculardisease prevention in clinical practice (Fourth Joint Task Force of the EuropeanSociety of Cardiology and other societies on cardiovascular disease prevention in308clinical practice). // Eur. J. Cardiovasc. Prev. Rehabil. – 2007. V.14, Suppl.2.
–P. S1-S113.286.Grasso M., Diegoli M., Brega A., Campana C., Tavazzi L., Arbustini E. Themitochondrial DNA mutation T12297C affects a highly conserved nucleotide oftRNA(Leu(CUN)) and is associated with dilated cardiomyopathy. // Eur. J. Hum.Genet. – 2001. V.9. Issue 4. P.311-315.287.Gropman A., Chen T.J., Perng C.L., Krasnewich D., Chernoff E., Tifft C.,WongL.J.VariableclinicalmanifestationofhomoplasmicG14459Amitochondrial DNA mutation. // Am. J.
Med. Genet. A. – 2004. V.124A. Issue 4. P.377-382.288.Gu L., Johnson M.W., Lusis A.J. Quantitative trail locus analysis of plasmalipoprotein levels in an autoimmmune mouse model. Interaction betweenlipoprotein metabolism, autoimmune disease and atherosclerosis. // Arterioscler.Thromb. Vase.
Biol. – 1999. – V.19. – P.442-453.289.Guan M.X., Fischel-Ghodsian N., Attardi G. Molecular pathogeneticmechanism of maternally inherited deafness. // Hum. Mol. Genet. – 1996. V.5. Issue 7. P.963-971.290.Guo Z.F., Guo W.S., Xiao L., Gao G.Q., Lan F., Lu X.G., Li K., Liao D.F.Discrimination of A1555G and C1494T Point Mutations in the Mitochondrial 12SrRNA Gene by On/Off Switch. // Appl. Biochem. Biotechnol. – 2011. V.166. Issue 1. P.234-242.291.Gutierrez J., Ballinger S.W., Darley-Usmar V.M., Landar A.
Free radicals,mitochondria, and oxidized lipids: the emerging role in signal transduction invascular cells. // Circ. Res. –2006. V.99. P.924-932.292. Halayko A.J., Solway J. Molecular mechanisms of phenotypic plasticity insmooth muscle cells. // J. Appl. Physiol. – 2001. V.90. – P.358-368.293. Hall J.G., Eis P.S., Law S.M. et al.
Sensitive detection of DNA polymorphismsby the serial invasive signal amplification reaction. // Proc. Natl. Acad. Sci. USA.– 2000. Jul.18; V.97. Issue 15. – P.8272-8277.309294.Han C.B., Ma J.M., Xin Y., Mao X.Y., Zhao Y.J., Wu D.Y., Zhang S.M.,Zhang Y.K. Mutations of mitochondrial 12S rRNA in gastric carcinoma and theirsignificance.
// World J. Gastroenterol. – 2005. V.11. Issue 1. P.31-35.295. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. // N.Engl. J. Med. – 2005. – V.352. – P.1685-1695.296. Hansson G.K., Libby P. The immune response in atherosclerosis: A doubleedged sword.
// Nat. Rev. Immunol. – 2006. – V.6. – P.508-519.297. Hao H., Gabbiani G., Bochaton-Piallat M.L. Arterial smooth muscle cellheterogeneity: implications for atherosclerosis and restenosis development. //Arterioscler. Thromb. Vasc. Biol. – 2003. – V.23. – P.1510-1520.298. Hecker R., Wang Z., Steger G. and Riesner D. Analysis of RNA structure bytemperature-gradient gel electrophoresis: viroid replication and processing. //Gene. – 1988. – V.72. – P.59-74.299. Heinonen P., Jartti L., Järvisalo M.J., Pesonen U., Kaprio J.A., Rönnemaa T.,Raitakari O.T., Scheinin M. Deletion polymorphism in the alpha2B-adrenergicreceptor gene is associated with flow-mediated dilatation of the brachial arter. //Clin.
Sci. (Lond). – 2002. – V.103. – Issue 5. – P.517-524.300. Hinz B., Phan S.H., Thannickal V.J., Galli A., Bochaton-Piallat M.L., GabbianiG. The myofibroblast: one function, multiple origins. // Am. J. Pathol. – 2007. –V.170. – P.1807-1816.301.Hirai M, Suzuki S, Onoda M, Hinokio Y, Ai L, Hirai A, Ohtomo M,Komatsu K, Kasuga S, Satoh Y, Akai H, Toyota T. Mitochondrial DNA 3394mutation in the NADH dehydrogenase subunit 1 associated with non-insulindependent diabetes mellitus. // Biochem.
Biophys. Res. Commun. – 1996. –V.219. – Issue 3. – P.951-955.302.Hoffbuhr K.C., Davidson E., Filiano B.A., Davidson M., Kennaway N.G.,King M.P. A pathogenic 15-base pair deletion in mitochondrial DNA-encodedcytochrome c oxidase subunit III results in the absence of functional cytochrome coxidase. // J. Biol. Chem. – 2000. – V.275. – Issue 18. – P.13994-14003.310303.Holland M.M., McQuillan M.R., O'Hanlon K.A. Second generationsequencing allows for mtDNA mixture deconvolution and high resolutiondetection of heteroplasmy.
// Croat. Med. J. – 2011. – Jun.; V.52. – Issue 3. –P.299-313.304. Holt I.J., Harding A.E., Morgan-Hughes J.A. Deletions of mitochondrial DNAin patients with mitochondrial myopathy. // Nature. – 1988. – V.331. – P.7179501.305. Horváth R, Scharfe C, Hoeltzenbein M, Do BH, Schröder C, Warzok R,Vogelgesang S, Lochmüller H, Müller-Höcker J, Gerbitz KD, Oefner PJ, JakschM. Childhood onset mitochondrial myopathy and lactic acidosis caused by a stopmutation in the mitochondrial cytochrome c oxidase III gene.
// J. Med. Genet. 2002. V.39. – Issue 11. P.812-816.306.307.http://blast.ncbi.nlm.nih.gov/Blast.cgi (дата обращения 11.01.2016).http://www.nedug.ru/library/c/Схема-строения-стенокартерий#.UoTE0RrIbv4 (дата обращения 17.01.2016).308.http://atvb.ahajournals.org (дата обращения 09.02.2016).309.http://www.atherosclerosis-journal.com (дата обращения 11.09.2016).310.http://smjournals.com/atherosclerosis/journal-scope.php(дата обращения11.12.2016).311. http://spss.ru.joydownload.com/&c=20?gclid=COTnxtbesLwCFaHbcgodiiMAtQ (дата обращения 17.
03.2016).312. http://www.qiagen.com/products/pyromarkq96id.aspx(датаобращения27.05.2016).313. http://russia.sibenzyme.com/info231.php. (дата обращения 29.01.2016).314. http://бмэ.орг/index.php/ВСЕМИРНАЯ_ОРГАНИЗАЦИЯ_ЗДРАВООХРАНЕНИЯ (дата обращения 19.05.2016).315.Hu Q, Zhang XJ, Liu CX, Wang XP, Zhang Y. PPARgamma1-inducedcaveolin-1 enhances cholesterol efflux and attenuates atherosclerosis inapolipoprotein E-deficient mice. // J. Vasc.
Res. – 2010. – V.47. – Issue 1. – P.6979.311316. Huijgen R, Vissers MN, Kindt I, Trip MD, de Groot E, Kastelein JJ, HuttenBA. Assessment of carotid atherosclerosis in normocholesterolemic individualswith proven mutations in the low-density lipoprotein receptor or apolipoprotein Bgenes. // Circ. Cardiovasc. Genet. – 2011. – V.4. – Issue 4.
– P.413-417.317.Hulsmans M., De Keyzer D., Holvoet P.. MicroRNAs regulating oxidativestress and inflammation in relation to obesity and atherosclerosis. // FASEB J. –2011. – V.25. – Issue 8. – P.2515-2527.318.Huoponen K. Leber hereditary optic neuropathy: clinical and moleculargenetic findings. // Neurogenetics. – 2001. – V.3. – Issue 3. – P.119-125.319.Hwang J.M., Chang B.L., Koh H.J., Kim J.Y., Park S.S. Leber's hereditaryoptic neuropathy with 3460 mitochondrial DNA mutation. // J. Korean. Med. Sci.– 2002. – V.17. – Issue 2.
– P.283-286.320.Ihling C., Bohrmann B., Schaefer H.E., Technau-Ihling K., Loeffler B.M.Endothelin-1 and endothelin converting enzyme-1 in human atherosclerosis-novel targets for pharmacotherapy in atherosclerosis. // Curr. Vasc. Pharmacol. –2004. – V.2. – Issue 3. – P.249-258.321. Ilyas M, Kim JS, Cooper J, Shin YA, Kim HM, Cho YS, Hwang S, Kim H,Moon J, Chung O, Jun J, Rastogi A, Song S, Ko J, Manica A, Rahman Z, HusnainT, Bhak J.
Whole genome sequencing of an ethnic Pathan (Pakhtun) from thenorth-west of Pakistan. // BMC Genomics. – 2015. – Mar.; V.12. – Issue 16. –P.172. doi:10.1186/s12864-015-1290-1.322. International Task Force for Prevention of Coronary Heart Disease. Pocketguide to prevention of coronary heart disease. // Boerm. Bruckmeier. Verlag.GmbH. – 2003. – 128 P.323.Irvine C.D., George S.J., Sheffield E., Johnson J.L., Davies A.H., LamontP.M. The association of platelet-derived growth factor receptor expression, plaquemorphology and histological features with symptoms in carotid atherosclerosis. //Cardiovasc. Surg.
– 2000. – V.8. – Issue 2. – P.121-129.324. Ishizaka Y., Ishizaka N., Tani M., Toda A., Toda E., Koike K., Yamakado M.Relationship between albuminuria, low eGFR, and carotid atherosclerosis in312Japanese women. // Kidney Blood Press. Res. – 2008. – V.31. – Issue 3. – P.164170.325. Ivey M.E., Osman N., Little P.J. Endothelin-1 signalling in vascular smoothmuscle: pathways controlling cellular functions associated with atherosclerosis. //Atherosclerosis. – 2008. – V.199. – Issue 2. – P.237-247.326.Jakel H., Fruchart-Najib J., Fruchart J.C. Retinoic acid receptor-relatedorphan receptor alpha as a therapeutic target in the treatment of dyslipidemia andatherosclerosis. // Drug News Perspect.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
